CGM Metrics Predict Imminent Progression to Type 1 Diabetes: Autoimmunity Screening for Kids (ASK) Study.

Andrea K SteckFran DongCristy Geno RasmussenKimberly BautistaFlor SepulvedaJudith BaxterLiping YuBrigitte I FrohnertMarian J Rewersnull nullnull null

Published in: Diabetes care (2021)

TA140 >10% is associated with a high risk of progression to clinical diabetes within the next year in autoantibody-positive children. CGM should be included in the ongoing monitoring of high-risk children and could be used as potential entry criterion for prevention trials.

Keyphrases

type diabetes
young adults
glycemic control
cardiovascular disease
insulin resistance
weight loss
celiac disease